Leafbuyer (LBUY) Financials

LBUY

Trailing 12 months to March 31, 2026

Revenue $4.5M -31.7% YoY

Net Income -$46K -111.4% YoY

Operating Cash Flow $390K -39.2% YoY

Gross Profit $2.1M -31.5% YoY

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Mar 31, 2026 Reported May 14, 2026 Currency USD FYE June

Newest figures come from the 10-Q for Q3 FY2026, filed May 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the LBUY SEC filings page.

Leafbuyer (LBUY) reported $4.5M in revenue over the twelve months to Mar 31, 2026, down 31.7% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI LBUY FY2025 2026-08-29

Operating leverage converted a larger revenue base into cash generation, while negative equity still constrains the balance sheet.

FY2025’s operating leverage is visible in a positive operating margin of 4.7% alongside operating cash flow of $855K: improved earnings reached cash generation, not just the income statement. That contrasts with FY2024, when operating income and operating cash flow were both negative, making the change a business-model inflection rather than a single bottom-line fluctuation.

Gross margin recovered to 43.7% while selling, general and administrative expense stayed around $1.9M in FY2025. With overhead broadly contained as gross profit expanded, the margin step-up is more consistent with better cost absorption or revenue mix than with simply increasing spending.

Cash conversion improved while balance-sheet capitalization remains negative: total equity was -$1.4M and the current ratio was 0.5x. The business generated cash from operations without yet rebuilding positive equity or matching near-term obligations with current assets.

Financial Health Signals

Financial health score not available

Leafbuyer does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress

-20.53

Leafbuyer scores -20.53, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($20.0M) relative to total liabilities ($2.5M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

7/8

Leafbuyer passes 7 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

3.28x

For every $1 of reported earnings, Leafbuyer generates $3.28 in operating cash flow ($855K OCF vs $261K net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate

3.75x

Leafbuyer earns $3.75 in operating income for every $1 of interest expense ($302K vs $81K). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.1M

YoY-34.7%

QoQ+17.2%

5Y CAGR+10.9%

10Y CAGR+44.2%

Leafbuyer generated $1.1M in revenue in Q3 2026. This represents a decrease of 34.7% from the same quarter a year earlier. Against the prior quarter it is up 17.2%.

EBITDA

$268K

Leafbuyer's EBITDA was $268K in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization.

Net Income

$139K

YoY-40.7%

QoQ+272.9%

Leafbuyer reported $139K in net income in Q3 2026. This represents a decrease of 40.7% from the same quarter a year earlier. Against the prior quarter it is up 272.9%.

EPS (Diluted)

$0.00

Leafbuyer earned $0.00 per diluted share (EPS) in Q3 2026.

Cash & Balance Sheet

Cash & Debt

$956K

YoY+60.6%

QoQ-1.3%

5Y CAGR+2.5%

Leafbuyer held $956K in cash as of Q3 2026; long-term debt is not reported for that period.

Shares Outstanding

100M

YoY0.0%

QoQ0.0%

5Y CAGR+2.4%

10Y CAGR+31.9%

Leafbuyer had 100M shares outstanding in Q3 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q3 2026.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Gross Margin

53.6%

YoY+6.7pp

QoQ+7.4pp

5Y CAGR+28.1pp

10Y CAGR-46.4pp

Leafbuyer's gross margin was 53.6% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 6.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 7.4 percentage points.

Operating Margin

11.0%

YoY-3.5pp

QoQ+17.9pp

5Y CAGR+74.9pp

Leafbuyer's operating margin was 11.0% in Q3 2026, reflecting core business profitability. This is down 3.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 17.9 percentage points.

Net Margin

12.3%

YoY-1.3pp

QoQ+20.7pp

Leafbuyer's net profit margin was 12.3% in Q3 2026, showing the share of revenue converted to profit. This is down 1.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 20.7 percentage points.

Return on Equity

Not reported for Q3 2026.

Capital Allocation

None of these metrics is reported for Q3 2026.

LBUY Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

LBUY quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15
Revenue	$4.5M	$6.5M+15.5%	$5.6M+10.0%	$5.1M+33.7%	$3.8M+42.8%	$2.7M+5.5%	$2.5M+41.3%	$1.8M+58.6%	$1.1M+18.8%	$950K+34.8%	$705K	N/A
Cost of Revenue	$2.4M	$3.6M+2.7%	$3.5M+24.9%	$2.8M+4.8%	$2.7M+39.6%	$1.9M+9.9%	$1.8M+37.1%	$1.3M	N/A	N/A	$0	N/A
Gross Profit	$2.1M	$2.8M+37.7%	$2.1M-8.7%	$2.2M+105.6%	$1.1M+51.2%	$723K-4.9%	$761K+52.0%	$500K-55.7%	$1.1M+18.8%	$950K+34.8%	$705K	N/A
SG&A Expenses	$1.6M	$1.9M+2.6%	$1.8M-6.6%	$2.0M+1.4%	$1.9M-12.2%	$2.2M-50.3%	$4.4M-14.0%	$5.1M+32.4%	$3.9M+217.8%	$1.2M+75.6%	$694K	N/A
Operating Income	-$49K	$302K+151.5%	-$587K-39.6%	-$420K+73.8%	-$1.6M+31.2%	-$2.3M+48.1%	-$4.5M+23.5%	-$5.9M-99.2%	-$2.9M-998.5%	-$268K-2491.4%	$11K-49.1%	$22K
EBITDA	N/A	$762K+2024.7%	$36K-88.2%	$304K	N/A	N/A	-$3.8M+30.8%	-$5.5M-86.0%	-$2.9M	N/A	$12K	N/A
Interest Expense	$76K	$81K-34.4%	$123K-27.0%	$168K-18.2%	$206K-11.8%	$233K-77.1%	$1.0M+249.7%	-$680K-1812.0%	-$36K-16055.0%	-$220	$0	$0
Income Tax	N/A	$0	$0	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$46K	$261K+136.7%	-$709K-21.2%	-$585K-161.2%	$956K+119.0%	-$5.0M-486.2%	$1.3M+119.9%	-$6.6M-119.9%	-$3.0M-1015.0%	-$267K-2210.2%	$13K-42.5%	$22K
EPS (Basic)	N/A	$0.00	$0.00	$0.00-100.0%	$0.01+116.7%	-$0.06-400.0%	$0.02	N/A	N/A	N/A	N/A	N/A
EPS (Diluted)	—	N/A	N/A	N/A	$0.01+116.7%	-$0.06	$0.01	N/A	N/A	N/A	N/A	N/A
Diluted Shares (Avg)	N/A	N/A	N/A	N/A	143M+69.6%	84M	243M	N/A	N/A	N/A	N/A	N/A

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Revenue	$1.1M-34.7%	$963K-43.9%	$973K-39.5%	$1.4M-5.6%	$1.7M+15.5%	$1.7M+19.7%	$1.6M+37.6%	$1.5M+12.5%
Cost of Revenue	$523K-43.0%	$518K-46.2%	$479K-44.3%	$906K+10.9%	$918K-1.7%	$963K-2.3%	$860K+5.8%	$817K+2.8%
Gross Profit	$605K-25.3%	$445K-41.0%	$494K-34.0%	$510K-25.4%	$811K+44.0%	$754K+68.1%	$749K+110.3%	$684K+26.8%
SG&A Expenses	$336K-10.8%	$395K-17.2%	$414K-23.5%	$476K+31.4%	$376K-20.8%	$477K+2.7%	$541K+3.9%	$362K-74.8%
Operating Income	$124K-50.6%	-$66K-168.2%	-$28K-187.6%	-$79K-171.1%	$252K+280.7%	$97K+149.1%	$32K+109.0%	$111K+142.3%
EBITDA	$268K	N/A	$79K-50.1%	N/A	N/A	N/A	$158K+188.0%	N/A
Interest Expense	$19K+4.9%	$19K-16.1%	$19K-9.7%	$19K-36.8%	$18K-44.0%	$23K-1.6%	$21K-44.2%	$30K-20.4%
Income Tax	N/A	N/A	$0	N/A	N/A	N/A	$0	N/A
Net Income	$139K-40.7%	-$81K-207.8%	-$44K-482.4%	-$61K-175.2%	$235K+237.0%	$75K+134.0%	$12K+102.9%	$81K+126.9%
EPS (Diluted)	$0.00	$0.00	$0.00	N/A	$0.00	$0.00	$0.00	N/A
Diluted Shares (Avg)	100M0.0%	100M0.0%	100M0.0%	N/A	100M+0.1%	100M+0.6%	100M-33.8%	N/A

Not reported in any period shown, so not listed: R&D Expenses, EPS (Basic).

LBUY Balance Sheet

LBUY quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15
Total Assets	$1.1M+29.3%	$874K-52.4%	$1.8M-22.5%	$2.4M-30.4%	$3.4M-31.6%	$5.0M+27.1%	$3.9M+597.7%	$561K+184.8%	$197K+152.9%	$78K+147.6%	$31K
Current Assets	$986K+265.0%	$270K-55.7%	$609K+45.3%	$419K-42.6%	$730K-48.3%	$1.4M+270.7%	$381K-32.0%	$560K+186.5%	$196K+150.9%	$78K+147.6%	$31K
Cash & Equivalents	$854K+416.4%	$165K-62.9%	$446K+21.4%	$367K-46.4%	$685K-47.7%	$1.3M+621.1%	$182K-51.7%	$376K+128.3%	$165K+161.4%	$63K+177.4%	$23K
Inventory	N/A	N/A	N/A	$0	$0-100.0%	$622-49.4%	$1K-65.2%	$4K	$0	N/A	N/A
Accounts Receivable	$118K+41.0%	$83K-38.4%	$135K+365.8%	$29K-7.6%	$31K+124.2%	$14K-79.6%	$69K+731.3%	$8K	$0	N/A	N/A
Total Liabilities	$2.5M-2.0%	$2.6M-18.0%	$3.1M-17.6%	$3.8M-64.4%	$10.6M+29.6%	$8.2M-40.9%	$13.9M+951.2%	$1.3M+1211.5%	$101K+5.1%	$96K+119.4%	$44K
Current Liabilities	$2.0M-5.0%	$2.1M-19.9%	$2.7M-18.8%	$3.3M-65.7%	$9.6M+36.1%	$7.0M+114.5%	$3.3M+148.6%	$1.3M+1211.5%	$101K+5.1%	$96K+119.4%	$44K
Non-Current Liabilities	$475K+13.3%	$419K-6.6%	$449K-10.2%	$500K-52.7%	$1.1M-9.4%	$1.2M-89.0%	$10.6M	$0	$0	$0	$0
Long-Term Debt	N/A	N/A	$478K-4.4%	$500K-52.7%	$1.1M-4.0%	$1.1M	$0	N/A	N/A	N/A	N/A
Total Equity	-$1.4M+18.3%	-$1.7M-31.5%	-$1.3M+9.5%	-$1.4M+80.4%	-$7.2M-124.1%	-$3.2M+67.6%	-$10.0M-1213.0%	-$758K-885.7%	$96K+641.9%	-$18K-46.3%	-$12K
Retained Earnings	-$24.9M+1.0%	-$25.1M-2.9%	-$24.4M-2.5%	-$23.9M+3.9%	-$24.8M-25.4%	-$19.8M+6.2%	-$21.1M-435.2%	-$3.9M-310.9%	-$959K-5285.0%	-$18K-46.3%	-$12K

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Total Assets	$1.1M-1.2%	$1.0M+11.8%	$1.0M+27.6%	$1.1M+29.3%	$1.1M+6.3%	$911K-27.2%	$807K-41.9%	$874K-52.4%
Current Assets	$1.1M+27.3%	$1.0M+85.5%	$994K+201.4%	$986K+265.0%	$868K+133.6%	$548K+41.1%	$330K-4.7%	$270K-55.7%
Cash & Equivalents	$956K+60.6%	$969K+115.1%	$912K+294.4%	$854K+416.4%	$595K+281.7%	$450K+98.7%	$231K+14.0%	$165K-62.9%
Accounts Receivable	$128K-49.8%	$39K-60.0%	$73K-19.5%	$118K+41.0%	$254K+30.7%	$97K-33.3%	$91K-28.4%	$83K-38.4%
Total Liabilities	$2.5M+1.3%	$2.5M+1.9%	$2.4M-0.2%	$2.5M-2.0%	$2.4M-14.3%	$2.5M-17.0%	$2.5M-17.7%	$2.6M-18.0%
Current Liabilities	$2.0M+3.1%	$2.1M+3.9%	$2.0M-3.0%	$2.0M-5.0%	$1.9M-18.2%	$2.0M-21.2%	$2.0M-18.7%	$2.1M-19.9%
Non-Current Liabilities	$453K-6.1%	$460K-6.0%	$467K+13.4%	$475K+13.3%	$482K+5.7%	$489K+5.6%	$412K-12.4%	$419K-6.6%
Total Equity	-$1.4M-3.5%	-$1.4M+9.0%	-$1.4M+13.9%	-$1.4M+18.3%	-$1.3M+26.5%	-$1.6M+9.6%	-$1.6M-3.5%	-$1.7M-31.5%
Retained Earnings	-$24.9M-0.2%	-$25.0M+0.2%	-$24.9M+0.8%	-$24.9M+1.0%	-$24.8M+1.6%	-$25.1M0.0%	-$25.1M-1.2%	-$25.1M-2.9%

Not reported in any period shown, so not listed: Short-Term Investments, Inventory, Long-Term Investments, Goodwill, Long-Term Debt.

LBUY Cash Flow Statement

LBUY quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15
Operating Cash Flow	$390K	$855K+752.4%	-$131K-131.0%	$423K+233.1%	-$317K+63.0%	-$858K+69.4%	-$2.8M+2.8%	-$2.9M-77.4%	-$1.6M-393.1%	-$330K-663.4%	$59K+779.6%	-$9K
Depreciation & Amortization	N/A	$459K-26.2%	$622K-14.1%	$724K	N/A	N/A	$695K+78.7%	$389K+61982.5%	$627	N/A	$743	N/A
Stock-Based Compensation	N/A	$48K-83.1%	$281K-35.1%	$432K+17.0%	$370K-26.7%	$504K-38.4%	$818K-64.2%	$2.3M+181.8%	$811K	N/A	N/A	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$2K	$0	$0
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$332K-665.9%	$59K+779.6%	-$9K
Investing Cash Flow	N/A	N/A	N/A	$0	$0	$0+100.0%	-$560K+39.3%	-$923K	N/A	-$2K	$0	$0
Financing Cash Flow	-$29K	-$167K-11.9%	-$149K+56.6%	-$344K	$0-100.0%	$233K-94.8%	$4.5M+24.3%	$3.6M+96.7%	$1.8M+314.3%	$444K+2525.7%	-$18K-9.4%	-$17K

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Operating Cash Flow	-$6K-103.7%	$64K-71.8%	$66K-68.7%	$266K+414.1%	$152K+384.6%	$226K+303.9%	$211K+213.9%	$52K-44.5%
Depreciation & Amortization	$143K	N/A	$108K-14.6%	N/A	N/A	N/A	$126K-30.5%	N/A
Stock-Based Compensation	$48K	N/A	$0-100.0%	N/A	N/A	N/A	$24K-72.4%	N/A
Financing Cash Flow	-$7K0.0%	-$7K0.0%	-$7K+95.0%	-$7K+82.7%	-$7K+57.8%	-$7K+77.4%	-$145K-153.2%	-$42K+48.6%

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Investing Cash Flow, Dividends Paid, Share Buybacks.

LBUY Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

LBUY quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15
Gross Margin	43.6%+7.0pp	36.6%-7.5pp	44.2%+15.4pp	28.7%+1.6pp	27.1%-3.0pp	30.1%+2.1pp	28.0%-72.0pp	100.0%0.0pp	100.0%0.0pp	100.0%	N/A
Operating Margin	4.7%+15.1pp	-10.5%-2.2pp	-8.3%+33.9pp	-42.2%+45.3pp	-87.4%	-177.7%	-328.2%	-261.4%	-28.3%-29.9pp	1.6%	N/A
Net Margin	4.0%+16.7pp	-12.7%-1.2pp	-11.5%-36.6pp	25.1%	-188.6%	51.5%	-366.2%	-264.1%	-28.1%-29.9pp	1.8%	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-277.0%	N/A	N/A
Return on Assets	23.1%+104.3pp	-81.2%-49.3pp	-31.9%-72.2pp	40.3%+188.1pp	-147.7%-173.9pp	26.2%+193.6pp	-167.4%+363.6pp	-531.0%-395.3pp	-135.6%-151.9pp	16.3%-53.8pp	70.0%
Current Ratio	0.49+0.4x	0.13-0.1x	0.23+0.1x	0.13+0.1x	0.08-0.1x	0.20+0.1x	0.12-0.3x	0.42-1.5x	1.94+1.1x	0.81+0.1x	0.72
Debt-to-Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	1.04	N/A	N/A
Asset Turnover	5.73-0.7x	6.41+3.6x	2.77+1.2x	1.61+0.8x	0.78+0.3x	0.51+0.1x	0.46-1.6x	2.01-2.8x	4.82-4.2x	9.04	N/A
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-34.9%-43.2pp	8.3%	N/A

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Gross Margin	53.6%+6.7pp	46.2%+2.3pp	50.8%+4.2pp	36.0%-9.5pp	46.9%+9.3pp	43.9%+12.6pp	46.6%+16.1pp	45.6%+5.2pp
Operating Margin	11.0%-3.5pp	-6.8%-12.5pp	-2.9%-4.9pp	-5.6%-13.0pp	14.6%+23.9pp	5.6%+19.4pp	2.0%+32.9pp	7.4%+27.1pp
Net Margin	12.3%-1.3pp	-8.4%-12.7pp	-4.5%-5.2pp	-4.3%-9.7pp	13.6%+25.1pp	4.4%+19.7pp	0.7%+34.8pp	5.4%+27.9pp
Return on Assets	12.6%-8.4pp	-7.9%-16.1pp	-4.3%-5.7pp	-5.4%-14.6pp	21.0%+37.3pp	8.2%+25.8pp	1.4%+30.1pp	9.3%+25.6pp
Current Ratio	0.55+0.1x	0.49+0.2x	0.50+0.3x	0.49+0.4x	0.45+0.3x	0.28+0.1x	0.160.0x	0.13-0.1x
Asset Turnover	1.02-0.5x	0.95-0.9x	0.94-1.0x	1.25-0.5x	1.54+0.1x	1.89+0.7x	1.99+1.2x	1.72+1.0x

Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity, FCF Margin.

Note: Shareholder equity is negative (-$1.4M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.49), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Leafbuyer LBUY	FY2025	$6.5M	$261K	4.0%	$20.0M	—
LEAFLY HOLDINGS INC LFLY	FY2024	$34.6M	-$5.7M	-16.6%	$1.1M	—

Where Leafbuyer Ranks

Frequently Asked Questions

What is Leafbuyer's annual revenue?

Leafbuyer (LBUY) reported $6.5M in total revenue for fiscal year 2025. This represents a 15.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Leafbuyer's revenue growing?

Leafbuyer (LBUY) revenue grew by 15.5% year-over-year, from $5.6M to $6.5M in fiscal year 2025.

Is Leafbuyer profitable?

Yes, Leafbuyer (LBUY) reported a net income of $261K in fiscal year 2025, with a net profit margin of 4.0%.

What is Leafbuyer's EBITDA?

Leafbuyer (LBUY) had EBITDA of $762K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Leafbuyer's gross margin?

Leafbuyer (LBUY) had a gross margin of 43.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Leafbuyer's operating margin?

Leafbuyer (LBUY) had an operating margin of 4.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Leafbuyer's net profit margin?

Leafbuyer (LBUY) had a net profit margin of 4.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Leafbuyer's operating cash flow?

Leafbuyer (LBUY) generated $855K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Leafbuyer's total assets?

Leafbuyer (LBUY) had $1.1M in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does Leafbuyer have outstanding?

Leafbuyer (LBUY) had 100M shares outstanding as of fiscal year 2025.

What is Leafbuyer's current ratio?

Leafbuyer (LBUY) had a current ratio of 0.49 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Leafbuyer's return on assets (ROA)?

Leafbuyer (LBUY) had a return on assets of 23.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Why is Leafbuyer's debt-to-equity ratio negative or not reported?

Leafbuyer (LBUY) has negative shareholder equity of -$1.4M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Leafbuyer's Altman Z-Score?

Leafbuyer (LBUY) has an Altman Z-Score of -20.53, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Leafbuyer's Piotroski F-Score?

Leafbuyer (LBUY) has a Piotroski F-Score of 7 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Leafbuyer's earnings high quality?

Leafbuyer (LBUY) has an earnings quality ratio of 3.28x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Leafbuyer cover its interest payments?

Leafbuyer (LBUY) has an interest coverage ratio of 3.75x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.